Equity Overview
Price & Market Data
Price: $0.745
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,164,951
Daily Volume: 0
Performance Metrics
1 Week: 39.23%
1 Month: -18.77%
3 Months: -63.49%
6 Months: -83.37%
1 Year: -93.27%
YTD: -58.62%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.